Why finished-formula testing matters more than ingredient marketing
Skincare marketing has shifted significantly toward ingredient-led communication. Consumers now recognise individual ingredient names — niacinamide, hyaluronic acid, ceramides — and associate them with specific outcomes. This shift has value: ingredient transparency is better than vague benefit language. But it has also produced a misunderstanding that the ingredient list is the product.
What an ingredient list tells you
An INCI (International Nomenclature of Cosmetic Ingredients) list tells you which ingredients are present in descending order of concentration (above 1%). It does not tell you the concentration of each ingredient. It does not tell you the form of the ingredient used (free acid, ester, salt, encapsulated). It does not tell you the pH of the formula — which affects whether certain actives are in their active form. It does not tell you stability, preservation efficacy or how the formula performs on actual skin over time.
What finished-formula testing tells you
Finished-formula testing evaluates the product as it will be applied — not the ingredient in isolation. Relevant tests for a skincare product include:
- Patch test / dermatologist tolerance test: conducted on human volunteers, evaluates skin tolerance under real-use conditions
- In-use consumer panel: self-assessment of hydration, comfort, skin feel and appearance outcomes over 4–8 weeks
- Biophysical measurement: corneometry (hydration), tewametry (TEWL), cutometry (elasticity) — objective, instrument-based
- Stability testing: confirms formula remains stable (separation, colour, odour, pH) over shelf life under accelerated conditions
- Microbiological challenge testing: confirms preservation efficacy against specified challenge organisms
- Safety assessment: EU Cosmetics Regulation requires a qualified safety assessor to certify product safety before market entry
Why Ambernay emphasises this
Ambernay products are developed through structured formulation briefs, testing partners and safety assessors. We do not assume that including a recognised ingredient at any concentration constitutes an efficacious product. We test the finished formula. When we communicate outcomes — barrier support, hydration, daily comfort — those claims are based on what the formula does, not on what individual ingredients are theoretically capable of.
This distinction is not common in the skincare market. Most ingredient marketing is extrapolated from isolated ingredient studies, not from the finished product in the form consumers will use. We think that gap matters and we communicate it directly.
